Abstract:
Background: Essential Hypertension (EH)  accounts  for  majority  of  hypertension  cases  globally. Genetic  factors  along  with haematological and  biochemical  changes  may  underlie  EH  and  these have not been well studied in Kenya. A meta-analysis in African populations (excluding East Africa) identified the 1166A>C (rs5186) single nucleotide polymorphism (SNP) in the angiotensin II type 1 receptor  gene  (AGTR1)  that  encodes  the  angiotensin  II  type  1  receptor  as  likely  to  predispose some Africans to hypertension.
 Aim: The purpose of the study was to determine whether the AGTR1 (rs5186) mutation, C-reactive protein (CRP) and selected haematological biomarkers may be associated with the onset of EHin Tharaka Nithi County, Kenya).
Study Design: A case control study design was adopted.
Place  and  Duration  of  Study: The  research  was  conducted  from  March  to  July  2022  at  Chuka County Referral Hospital in Tharaka Nithi County. Methodology: A total of 272 participants, both hypertensive and normotensive, were recruited and blood samples obtained.  DNA was extracted and analyzed by PCR RFLP.  Independent  T-test, Mann Whitney  U  test  and  Odds  ratios  were  used  to  compare  the  two  groups.  P values less than 0.05 were considered statistically significant. 
Results: Median  values  for  Red  Cell  Distribution  Width  (RDW),  C-reactive  Protein  (CRP)  and mean  values  for  Mean  Platelet  Volume  (MPV)  and  Neutrophil  to  Lymphocyte  ratio  (NLR)  were significantly  higher  (P  <  .001)  in  hypertensive  group  compared  to  normotensive  individuals.  Mean Platelet  Distribution  Width  (PDW)  was  not  significantly  different  between  cases  and  controls. (P=.519) There was no significant association between the AGTR11166A>C (rs5186) SNP frequency and EH in both groups (P=0.6236, OR=0.4952(95%CI:0.0442-5.5456)
Conclusion: The AGTR1 (rs5186) SNP is not associated with EH in Tharaka Nithi County, Kenya. EH  is  associated  with  elevated  levels  of  CRP,  RDW,  MPV  and  NLR  in  the  absence  of  other inflammatory and chronic diseases. Further studies of the genetics of hypertension in Kenya need to be conducted.